Logo

Ansa Bio: Matthew McManus

Feb 23, 2023

Ansa Bio has appointed Matthew McManus as its independent director and chairperson of the company's board of directors. McManus most recently served as the executive VP and CFO at Azenta. Before that, he was the senior VP and general manager of the molecular diagnostics division at Bio-Techne. McManus has also served as the president and CEO of PrimeraDx, a company that was acquired by Qiagen. McManus received his MD and PhD from the University of Pennsylvania, MBA from Boston College, and BA in economics from College of the Holy Cross.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.